Najia K. Ghanchi

Stadium Road
Karachi, SD, Pakistan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 72 publications

Dissemination of trial results to study participants in Cambodia, Ethiopia and Pakistan: a qualitative study.

Dissemination of trial results to study participants in Cambodia, Ethiopia and Pakistan: a qualitative study.

Journal: BMJ open
Published: August 10, 2026

Molecularepidemiology and antimicrobial resistance determinants of Corynebacterium diphtheriae causing infections in Karachi, Pakistan, 2023-2024.

Molecularepidemiology and antimicrobial resistance determinants of Corynebacterium diphtheriae causing infections in Karachi, Pakistan, 2023-2024.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: April 14, 2026

Incidence of Dengue Fever in Pakistan.

Incidence of Dengue Fever in Pakistan.

Journal: PloS one
Published: February 25, 2026

Stillbirth and Infection.

Stillbirth and Infection.

Journal: Clinics in perinatology
Published: February 18, 2026

Genetic evidence of cross-border Plasmodium vivax spread in a malaria pre-elimination region of South Asia.

Genetic evidence of cross-border Plasmodium vivax spread in a malaria pre-elimination region of South Asia.

Journal: The Journal of infectious diseases
Published: February 16, 2026

Correction: Spatio-temporal distribution of Crimean-Congo Hemorrhagic Fever and its relationship with climate factors in Pakistan: A decade-long experience from tertiary care laboratory network.

Correction: Spatio-temporal distribution of Crimean-Congo Hemorrhagic Fever and its relationship with climate factors in Pakistan: A decade-long experience from tertiary care laboratory network.

Journal: PloS one
Published: January 20, 2026

Maternal circulating sFlt-1/placental growth factor is a biomarker of fetal death associated with placental lesions of maternal vascular malperfusion.

Maternal circulating sFlt-1/placental growth factor is a biomarker of fetal death associated with placental lesions of maternal vascular malperfusion.

Journal: Journal of perinatal medicine
Published: November 10, 2025

Detection of Acute Tropical Fever Pathogens via Multiplex Polymerase Chain Reaction: A Cross-Sectional Study to Guide Appropriate Antimicrobial Use in Communities.

Detection of Acute Tropical Fever Pathogens via Multiplex Polymerase Chain Reaction: A Cross-Sectional Study to Guide Appropriate Antimicrobial Use in Communities.

Journal: Cureus
Published: October 28, 2025

SQLE mutations and antifungal susceptibility profile of Trichophyton species isolated from patients with recalcitrant dermatophytosis: A laboratory-based study from Pakistan.

SQLE mutations and antifungal susceptibility profile of Trichophyton species isolated from patients with recalcitrant dermatophytosis: A laboratory-based study from Pakistan.

Journal: Medical mycology
Published: October 07, 2025

Effectiveness of tafenoquine and primaquine for radical cure of Plasmodium vivax: a meeting report from dissemination of results of the EFFORT trial to stakeholders in Pakistan.

Effectiveness of tafenoquine and primaquine for radical cure of Plasmodium vivax: a meeting report from dissemination of results of the EFFORT trial to stakeholders in Pakistan.

Journal: Malaria journal
Published: October 02, 2025

First Case of Candidemia With Fluconazole-Resistant Candida albicans and Y132H Mutations in ERG11 Gene From Pakistan.

First Case of Candidemia With Fluconazole-Resistant Candida albicans and Y132H Mutations in ERG11 Gene From Pakistan.

Journal: Case reports in infectious diseases
Published: October 02, 2025

Effectiveness and safety of 7-day high-dose primaquine and single-dose tafenoquine versus 14-day low-dose primaquine in patients with Plasmodium vivax malaria (EFFORT): a multicentre, open-label, randomised, controlled, superiority trial.

Effectiveness and safety of 7-day high-dose primaquine and single-dose tafenoquine versus 14-day low-dose primaquine in patients with Plasmodium vivax malaria (EFFORT): a multicentre, open-label, randomised, controlled, superiority trial.

Journal: The Lancet. Infectious diseases
Published: September 04, 2025
Showing 1-12 of 72

Last Updated: 09/26/2026